#ACTRIMS2017 – Lemtrada Maintains Durable Positive Effects in MS Without Additional Treatment
News
Two Phase 3 clinical trials investigating the long-term effects of Lemtrada (alemtuzumab) in multiple sclerosis (MS) patients showed the drug maintained improved outcomes, even in the ... Read more